Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending September 30, 2013. The report details a specific share repurchase transaction executed in accordance with shareholder authority granted at the Annual General Meeting on May 1, 2013.
Key Financial Metrics
The filing does not provide data on revenue, profit, cash flow, margins, debt, or liquidity. It focuses exclusively on capital structure changes related to share buybacks.
- Shares Purchased: 1,600,000 Ordinary Shares of 25 pence each.
- Purchase Date: September 30, 2013.
- Price Range: Highest price paid was 1,569 pence per share; lowest price paid was 1,554 pence per share.
- Treasury Holdings (Settled): 479,674,412 shares (8.94% of total issued share capital).
- Treasury Holdings (Including Unsettled): 484,364,412 shares (9.91% of current total voting rights).
- Shares in Issue (Excluding Treasury): 4,885,824,439 shares.
Material Changes
The primary material change is the reduction of outstanding shares through the purchase of 1,600,000 shares for Treasury. Consequently, the Company's total voting rights held in Treasury increased to 9.91% when including unsettled transactions.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It is a compliance disclosure confirming conformity with the Financial Conduct Authority's Disclosure and Transparency Rules.
Investor Verification Checklist
- Verify the total number of shares held in Treasury (479,674,412 settled) against the company's latest capitalization table.
- Confirm the percentage of total voting rights held in Treasury (9.91% including unsettled shares) for disclosure threshold calculations.
- Check the number of shares in issue excluding Treasury (4,885,824,439) to ensure accurate denominator usage for shareholder notification requirements.
- Review the price range paid (1,554 to 1,569 pence) to assess the cost of capital return relative to market prices on September 30, 2013.